Literature DB >> 2042064

Intraperitoneal chemotherapy.

M Markman1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2042064

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  14 in total

1.  Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.

Authors:  M Markman; W Jones; J L Lewis; S Rubin; T Hakes; B Reichman; R Barakat; J Curtin; L Almadrones; W Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.

Authors:  Csilla Hasovits; Stephen Clarke
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

3.  Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.

Authors:  M Markman; B Reichman; T Hakes; J Curtin; R Barakat; S Rubin; W Jones; J L Lewis; L Almadrones; W Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 4.  Regional chemotherapy: revisited.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center.

Authors:  Joseph A Kuhn; James M McLoughlin; Daniel C Harris; Loraye J Talaasen; Steven W Sutton; Todd M McCarty
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

6.  Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.

Authors:  Yutaka Yonemura; Ayman Elnemr; Yoshio Endou; Mitsumasa Hirano; Akiyoshi Mizumoto; Nobuyuki Takao; Masumi Ichinose; Masahiro Miura; Yan Li
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

7.  Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy.

Authors:  S S Ubhi; P McCulloch; P S Veitch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.

Authors:  M Markman; B Reichman; T Hakes; R Barakat; J Curtin; S Rubin; W Jones; J L Lewis; L Almadrones; W Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.

Authors:  G Los; L Tuyt; M van Vugt; J Schornagel; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.

Authors:  Zhi-Gang Wei; Guo-Xin Li; Xiang-Cheng Huang; Li Zhen; Jiang Yu; Hai-Jun Deng; Shan-Hua Qing; Ce Zhang
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.